×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Sierra Oncology Inc. (SRRA) NASDAQ

$54.99 0.02 (0.04%)

Market Cap: -

As of 06/30/22 04:00 PM EDT. Market closed.

(SRRA)

Sierra Oncology Inc. (SRRA)
NASDAQ

$54.99
0.02 (0.04%)

Market Cap: -

As of 06/30/22 04:00 PM EDT. Market closed.

Add to Portfolio

Sierra Oncology is a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer. Sierra Oncology harnesses its deep scientific expertise to identify compounds that target the root cause of disease to advance targeted therapies with assets on the leading edge of cancer biology. Its team takes an evidence-based approach to understand the ... read more

Sierra Oncology is a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer. Sierra Oncology harnesses its deep scientific expertise to identify compounds that target the root cause of disease to advance targeted therapies with assets on the leading edge of cancer biology. Its team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer treatment paradigm. Sierra Oncology is transforming promise into patient impact. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Stephen Dilly
Full Time Employees
69
URL
Address
2150 ? 885 West Georgia Street, British Columbia, Vancouver, V6C 3E8.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Stephen Dilly
Full Time Employees
69
Address
2150 ? 885 West Georgia Street, British Columbia, Vancouver, V6C 3E8.
PRICE CHART FOR SIERRA ONCOLOGY INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$54.97
Days Range
$54.98 - $55.17
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
24,419,349
Open
-
Previous Close
$54.97
Days Range
$54.98 - $55.17
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
24,419,349
FINANCIAL STATEMENTS FOR SIERRA ONCOLOGY INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SIERRA ONCOLOGY INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Vivo Opportunity, LLCDirectorJul 01, 2022 Option Exercise$55.00431,94723,757,0850Jul 01, 2022, 04:59 PM
Vivo Opportunity, LLCDirectorJul 01, 2022 Option Exercise$55.002,735,853150,471,9150Jul 01, 2022, 04:59 PM
Vivo Opportunity, LLCDirectorJul 01, 2022 Option Exercise$55.00161,7128,894,1600Jul 01, 2022, 04:59 PM
ORBIMED ADVISORS LLCDirectorJul 01, 2022 Option Exercise$55.001,964,770108,062,3500Jul 01, 2022, 04:50 PM
Ashiya MonaDirectorJul 01, 2022 Option Exercise$55.001,964,770108,062,3500Jul 01, 2022, 04:46 PM
Aggarwal GauravDirectorJul 01, 2022 Option Exercise$55.002,735,853150,471,9150Jul 01, 2022, 04:45 PM
Sinclair AndrewDirectorJul 01, 2022 Option Exercise$55.001,314,12772,276,9850Jul 01, 2022, 04:44 PM
Klencke BarbaraChief Medical OfficerJul 01, 2022 Option Exercise$55.005,000275,0000Jul 01, 2022, 04:43 PM
Klencke BarbaraChief Medical OfficerJul 01, 2022 Option Exercise$55.0010,000550,0000Jul 01, 2022, 04:43 PM
Allen Andrew RDirectorJul 01, 2022 Option Exercise$55.001,65090,7500Jul 01, 2022, 04:38 PM
Collard Craig ADirectorJul 01, 2022 Option Exercise$55.0013,500742,5000Jul 01, 2022, 04:37 PM
DILLY STEPHEN GEORGECEO and PresidentJul 01, 2022 Option Exercise$55.005,000275,0000Jul 01, 2022, 04:35 PM
Turner William D.Chief Reg & Tech Ops OfficerApr 06, 2022 Option Exercise$12.056,34776,4816,347Apr 07, 2022, 04:12 PM
Turner William D.Chief Reg & Tech Ops OfficerApr 05, 2022 Option Exercise$12.051001,205100Apr 07, 2022, 04:12 PM
Turner William D.Chief Reg & Tech Ops OfficerApr 06, 2022 Sale$37.256,347236,4090Apr 07, 2022, 04:12 PM
Turner William D.Chief Reg & Tech Ops OfficerApr 05, 2022 Sale$37.091003,7090Apr 07, 2022, 04:12 PM
Thomson Mary ChristinaGeneral Counsel, CCO & Sec'yApr 04, 2022 Option Exercise$13.042,00026,0802,000Apr 04, 2022, 07:25 PM
Thomson Mary ChristinaGeneral Counsel, CCO & Sec'yApr 04, 2022 Sale$35.142,00070,2770Apr 04, 2022, 07:25 PM
Turner William D.Chief Reg & Tech Ops OfficerMar 18, 2022 Option Exercise$12.051001,205100Mar 22, 2022, 04:15 PM
Turner William D.Chief Reg & Tech Ops OfficerMar 18, 2022 Sale$37.051003,7050Mar 22, 2022, 04:15 PM
Turner William D.Chief Reg & Tech Ops OfficerMar 17, 2022 Option Exercise$12.053,45341,6093,453Mar 17, 2022, 06:33 PM
Turner William D.Chief Reg & Tech Ops OfficerMar 17, 2022 Sale$37.063,453127,9540Mar 17, 2022, 06:33 PM
Thomson Mary ChristinaGeneral Counsel, CCO & Sec'yMar 04, 2022 Option Exercise$13.042,00026,0802,000Mar 04, 2022, 04:12 PM
Thomson Mary ChristinaGeneral Counsel, CCO & Sec'yMar 04, 2022 Sale$30.602,00061,1960Mar 04, 2022, 04:12 PM
Turner William D.Chief Reg & Tech Ops OfficerFeb 07, 2022 Option Exercise$12.0510,000120,50010,000Feb 08, 2022, 04:03 PM
Turner William D.Chief Reg & Tech Ops OfficerFeb 07, 2022 Sale$32.3210,000323,2250Feb 08, 2022, 04:03 PM
Thomson Mary ChristinaGeneral Counsel, CCO & Sec'yFeb 04, 2022 Option Exercise$13.042,00026,0802,000Feb 04, 2022, 04:08 PM
Thomson Mary ChristinaGeneral Counsel, CCO & Sec'yFeb 04, 2022 Sale$29.782,00059,5600Feb 04, 2022, 04:08 PM
Longitude Capital Partners III, LLC10% OwnerFeb 02, 2022 Buy$27.00175,0004,725,000175,000Feb 02, 2022, 09:25 PM
Richardson JoshuaDirectorFeb 02, 2022 Buy$27.00175,0004,725,000175,000Feb 02, 2022, 09:24 PM
Sinclair AndrewDirectorJan 31, 2022 Buy$27.00150,0004,050,0001,314,127Feb 01, 2022, 05:04 PM
Sinclair AndrewDirectorJan 28, 2022 Option Exercise$13.20287,4713,794,6171,164,127Feb 01, 2022, 05:04 PM
Abingworth LLP10% OwnerJan 31, 2022 Buy$27.00150,0004,050,0001,314,127Feb 01, 2022, 05:00 PM
Abingworth LLP10% OwnerJan 28, 2022 Option Exercise$13.20287,4713,794,6171,164,127Feb 01, 2022, 05:00 PM
Vivo Opportunity, LLC10% OwnerJan 31, 2022 Buy$27.00800,00021,600,0002,735,853Jan 31, 2022, 09:30 PM
Aggarwal GauravDirectorJan 31, 2022 Buy$27.00800,00021,600,0002,735,853Jan 31, 2022, 06:47 PM
Ashiya MonaDirectorJan 26, 2022 Option Exercise$13.2056,244742,421226,704Jan 28, 2022, 09:23 PM
Ashiya MonaDirectorJan 26, 2022 Option Exercise$13.20431,2065,691,9191,511,362Jan 28, 2022, 09:23 PM
ORBIMED ADVISORS LLCDirectorJan 26, 2022 Option Exercise$13.2056,244742,421226,704Jan 28, 2022, 09:22 PM
ORBIMED ADVISORS LLCDirectorJan 26, 2022 Option Exercise$13.20431,2065,691,9191,511,362Jan 28, 2022, 09:22 PM
Vivo Opportunity, LLC10% OwnerJan 26, 2022 Option Exercise$13.20480,2776,339,6561,935,853Jan 28, 2022, 08:12 PM
Vivo Opportunity, LLC10% OwnerJan 26, 2022 Option Exercise$13.2024,996329,947161,712Jan 28, 2022, 08:12 PM
Vivo Opportunity, LLC10% OwnerJan 26, 2022 Option Exercise$13.20107,1641,414,565431,947Jan 28, 2022, 08:12 PM
Aggarwal GauravDirectorJan 26, 2022 Option Exercise$13.20480,2776,339,6561,935,853Jan 28, 2022, 07:53 PM
Thomson Mary ChristinaGeneral Counsel & SecretaryJan 26, 2022 Option Exercise$13.042,00026,0802,000Jan 28, 2022, 04:47 PM
Thomson Mary ChristinaGeneral Counsel & SecretaryJan 26, 2022 Sale$29.002,00058,0000Jan 28, 2022, 04:47 PM
Turner William D.Chief Reg & Tech Ops OfficerJan 26, 2022 Option Exercise$12.055,00060,2505,000Jan 28, 2022, 04:39 PM
Turner William D.Chief Reg & Tech Ops OfficerJan 26, 2022 Sale$27.055,000135,2500Jan 28, 2022, 04:39 PM
Longitude Capital Partners III, LLC10% OwnerJan 25, 2022 Option Exercise$13.20487,4516,434,3531,964,771Jan 27, 2022, 09:23 PM
Richardson JoshuaDirectorJan 25, 2022 Option Exercise$13.20487,4516,434,3531,964,771Jan 27, 2022, 09:22 PM
Collard Craig ADirectorNov 24, 2021 Buy$23.087,899182,34813,500Nov 24, 2021, 07:07 PM
Collard Craig ADirectorNov 23, 2021 Buy$22.945,601128,5155,601Nov 24, 2021, 07:07 PM
DILLY STEPHEN GEORGECEO and PresidentMay 19, 2021 Buy$17.835,00089,1505,000May 20, 2021, 06:59 PM
Klencke BarbaraChief Development OfficerAug 18, 2020 Buy$12.225,95072,71010,000Aug 18, 2020, 08:16 PM
Klencke BarbaraChief Development OfficerAug 18, 2020 Buy$12.253,32540,7385,000Aug 18, 2020, 08:16 PM
Klencke BarbaraChief Development OfficerAug 23, 2019 Buy$0.44108,00047,380162,000Aug 26, 2019, 05:07 PM
Klencke BarbaraChief Development OfficerAug 22, 2019 Buy$0.4554,00024,29554,000Aug 26, 2019, 05:07 PM
Klencke BarbaraChief Development OfficerAug 22, 2019 Buy$0.4367,00028,96467,000Aug 26, 2019, 05:07 PM
Allen Andrew RDirectorDec 10, 2018 Buy$1.6466,000108,24066,000Dec 11, 2018, 05:38 PM
You AngieChief Bus. & Strat. OfficerMar 08, 2017 Buy$1.4330,00042,900133,252Mar 09, 2017, 06:01 PM
Topper James NDirectorFeb 14, 2017 Buy$1.355,925,9268,000,0005,925,926Feb 16, 2017, 05:11 PM
Chapman WendySVP Clinical OperationsMar 22, 2016 Option Exercise$0.973,0002,9073,000Mar 24, 2016, 05:17 PM
Chapman WendySVP Clinical OperationsMar 22, 2016 Sale$7.013,00021,0230Mar 24, 2016, 05:17 PM
Chapman WendySVP Clinical OperationsFeb 22, 2016 Option Exercise$0.973,0002,9073,000Feb 24, 2016, 05:07 PM
Chapman WendySVP Clinical OperationsFeb 22, 2016 Sale$7.063,00021,1800Feb 24, 2016, 05:07 PM
Chapman WendySVP Clinical OperationsJan 22, 2016 Option Exercise$0.975,0004,8455,000Jan 25, 2016, 07:20 PM
Chapman WendySVP Clinical OperationsJan 22, 2016 Sale$9.395,00046,9730Jan 25, 2016, 07:20 PM
Rodigueza WendiChief Scientific OfficerJan 22, 2016 Sale$9.661,0009,660156,276Jan 22, 2016, 04:55 PM
Rodigueza WendiChief Scientific OfficerJan 21, 2016 Sale$10.321,00010,323157,276Jan 22, 2016, 04:55 PM
Rodigueza WendiChief Scientific OfficerJan 20, 2016 Sale$9.591,0009,590158,276Jan 22, 2016, 04:55 PM
Glover NicholasCEO and PresidentJan 15, 2016 Option Exercise$0.975,0004,8455,000Jan 19, 2016, 07:00 PM
Glover NicholasCEO and PresidentJan 15, 2016 Sale$10.045,00050,2230Jan 19, 2016, 07:00 PM
Lovejoy Chandra DSVP of Reg. Affairs & QualityJan 12, 2016 Option Exercise$0.977,5517,31720,973Jan 14, 2016, 05:16 PM
Lovejoy Chandra DSVP of Reg. Affairs & QualityJan 12, 2016 Sale$11.2920,973236,8335,562Jan 14, 2016, 05:16 PM
VIVO VENTURES VII, LLCFormer 10% holderJul 21, 2015 Option Exercise$5.222,32412,1202,218,270Jul 21, 2015, 07:06 PM
VIVO VENTURES VII, LLCFormer 10% holderJul 21, 2015 Option Exercise$5.22106,647556,1642,215,946Jul 21, 2015, 07:06 PM
VIVO VENTURES VII, LLCFormer 10% holderJul 21, 2015 Buy$17.004,69379,7812,438,270Jul 21, 2015, 07:06 PM
VIVO VENTURES VII, LLCFormer 10% holderJul 21, 2015 Buy$17.00215,3073,660,2192,433,577Jul 21, 2015, 07:06 PM
Vitangcol AlvinDirectorJul 21, 2015 Option Exercise$5.2239,889208,021798,762Jul 21, 2015, 07:05 PM
Topper James NDirectorJul 21, 2015 Option Exercise$5.2296,589503,7121,966,195Jul 21, 2015, 07:04 PM
Topper James NDirectorJul 21, 2015 Buy$17.00220,0003,740,0002,186,195Jul 21, 2015, 07:04 PM
Thompson Peter A.DirectorJul 21, 2015 Option Exercise$5.2289,159464,9641,814,949Jul 21, 2015, 07:03 PM
Thompson Peter A.DirectorJul 21, 2015 Buy$17.00175,0002,975,0001,989,949Jul 21, 2015, 07:03 PM
Parfet Donald RChairman of the BoardJul 21, 2015 Option Exercise$5.224,41323,014142,255Jul 21, 2015, 07:02 PM
Parfet Donald RChairman of the BoardJul 21, 2015 Option Exercise$5.228194,27165,779Jul 21, 2015, 07:02 PM
Parfet Donald RChairman of the BoardJul 21, 2015 Option Exercise$5.224,11921,481217,903Jul 21, 2015, 07:02 PM
Parfet Donald RChairman of the BoardJul 21, 2015 Option Exercise$5.221,5528,094770,045Jul 21, 2015, 07:02 PM
ORBIMED ADVISORS LLCDirectorJul 21, 2015 Option Exercise$5.2289,159464,9641,814,949Jul 21, 2015, 07:00 PM
ORBIMED ADVISORS LLCDirectorJul 21, 2015 Buy$17.00175,0002,975,0001,989,949Jul 21, 2015, 07:00 PM
CHA ALBERTDirectorJul 21, 2015 Option Exercise$5.22106,647556,1642,215,946Jul 21, 2015, 06:59 PM
CHA ALBERTDirectorJul 21, 2015 Option Exercise$5.222,32412,1202,218,270Jul 21, 2015, 06:59 PM
CHA ALBERTDirectorJul 21, 2015 Buy$17.004,69379,7812,438,270Jul 21, 2015, 06:59 PM
CHA ALBERTDirectorJul 21, 2015 Buy$17.00215,3073,660,2192,433,577Jul 21, 2015, 06:59 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Vivo Opportunity, LLCDirector07/01/202223,757,085
Vivo Opportunity, LLCDirector07/01/2022150,471,915
Vivo Opportunity, LLCDirector07/01/20228,894,160
ORBIMED ADVISORS LLCDirector07/01/2022108,062,350
Ashiya MonaDirector07/01/2022108,062,350
Aggarwal GauravDirector07/01/2022150,471,915
Sinclair AndrewDirector07/01/202272,276,985
Klencke BarbaraChief Medical Officer07/01/2022275,000
Klencke BarbaraChief Medical Officer07/01/2022550,000
Allen Andrew RDirector07/01/202290,750
Collard Craig ADirector07/01/2022742,500
DILLY STEPHEN GEORGECEO and President07/01/2022275,000
Turner William D.Chief Reg & Tech Ops Officer04/06/202276,481
Turner William D.Chief Reg & Tech Ops Officer04/05/20221,205
Turner William D.Chief Reg & Tech Ops Officer04/06/2022236,409
Turner William D.Chief Reg & Tech Ops Officer04/05/20223,709
Thomson Mary ChristinaGeneral Counsel, CCO & Sec'y04/04/202226,080
Thomson Mary ChristinaGeneral Counsel, CCO & Sec'y04/04/202270,277
Turner William D.Chief Reg & Tech Ops Officer03/18/20221,205
Turner William D.Chief Reg & Tech Ops Officer03/18/20223,705
Turner William D.Chief Reg & Tech Ops Officer03/17/202241,609
Turner William D.Chief Reg & Tech Ops Officer03/17/2022127,954
Thomson Mary ChristinaGeneral Counsel, CCO & Sec'y03/04/202226,080
Thomson Mary ChristinaGeneral Counsel, CCO & Sec'y03/04/202261,196
Turner William D.Chief Reg & Tech Ops Officer02/07/2022120,500
Turner William D.Chief Reg & Tech Ops Officer02/07/2022323,225
Thomson Mary ChristinaGeneral Counsel, CCO & Sec'y02/04/202226,080
Thomson Mary ChristinaGeneral Counsel, CCO & Sec'y02/04/202259,560
Longitude Capital Partners III, LLC10% Owner02/02/20224,725,000
Richardson JoshuaDirector02/02/20224,725,000
Sinclair AndrewDirector01/31/20224,050,000
Sinclair AndrewDirector01/28/20223,794,617
Abingworth LLP10% Owner01/31/20224,050,000
Abingworth LLP10% Owner01/28/20223,794,617
Vivo Opportunity, LLC10% Owner01/31/202221,600,000
Aggarwal GauravDirector01/31/202221,600,000
Ashiya MonaDirector01/26/2022742,421
Ashiya MonaDirector01/26/20225,691,919
ORBIMED ADVISORS LLCDirector01/26/2022742,421
ORBIMED ADVISORS LLCDirector01/26/20225,691,919
Vivo Opportunity, LLC10% Owner01/26/20226,339,656
Vivo Opportunity, LLC10% Owner01/26/2022329,947
Vivo Opportunity, LLC10% Owner01/26/20221,414,565
Aggarwal GauravDirector01/26/20226,339,656
Thomson Mary ChristinaGeneral Counsel & Secretary01/26/202226,080
Thomson Mary ChristinaGeneral Counsel & Secretary01/26/202258,000
Turner William D.Chief Reg & Tech Ops Officer01/26/202260,250
Turner William D.Chief Reg & Tech Ops Officer01/26/2022135,250
Longitude Capital Partners III, LLC10% Owner01/25/20226,434,353
Richardson JoshuaDirector01/25/20226,434,353
Collard Craig ADirector11/24/2021182,348
Collard Craig ADirector11/23/2021128,515
DILLY STEPHEN GEORGECEO and President05/19/202189,150
Klencke BarbaraChief Development Officer08/18/202072,710
Klencke BarbaraChief Development Officer08/18/202040,738
Klencke BarbaraChief Development Officer08/23/201947,380
Klencke BarbaraChief Development Officer08/22/201924,295
Klencke BarbaraChief Development Officer08/22/201928,964
Allen Andrew RDirector12/10/2018108,240
You AngieChief Bus. & Strat. Officer03/08/201742,900
Topper James NDirector02/14/20178,000,000
Chapman WendySVP Clinical Operations03/22/20162,907
Chapman WendySVP Clinical Operations03/22/201621,023
Chapman WendySVP Clinical Operations02/22/20162,907
Chapman WendySVP Clinical Operations02/22/201621,180
Chapman WendySVP Clinical Operations01/22/20164,845
Chapman WendySVP Clinical Operations01/22/201646,973
Rodigueza WendiChief Scientific Officer01/22/20169,660
Rodigueza WendiChief Scientific Officer01/21/201610,323
Rodigueza WendiChief Scientific Officer01/20/20169,590
Glover NicholasCEO and President01/15/20164,845
Glover NicholasCEO and President01/15/201650,223
Lovejoy Chandra DSVP of Reg. Affairs & Quality01/12/20167,317
Lovejoy Chandra DSVP of Reg. Affairs & Quality01/12/2016236,833
VIVO VENTURES VII, LLCFormer 10% holder07/21/201512,120
VIVO VENTURES VII, LLCFormer 10% holder07/21/2015556,164
VIVO VENTURES VII, LLCFormer 10% holder07/21/201579,781
VIVO VENTURES VII, LLCFormer 10% holder07/21/20153,660,219
Vitangcol AlvinDirector07/21/2015208,021
Topper James NDirector07/21/2015503,712
Topper James NDirector07/21/20153,740,000
Thompson Peter A.Director07/21/2015464,964
Thompson Peter A.Director07/21/20152,975,000
Parfet Donald RChairman of the Board07/21/201523,014
Parfet Donald RChairman of the Board07/21/20154,271
Parfet Donald RChairman of the Board07/21/201521,481
Parfet Donald RChairman of the Board07/21/20158,094
ORBIMED ADVISORS LLCDirector07/21/2015464,964
ORBIMED ADVISORS LLCDirector07/21/20152,975,000
CHA ALBERTDirector07/21/2015556,164
CHA ALBERTDirector07/21/201512,120
CHA ALBERTDirector07/21/201579,781
CHA ALBERTDirector07/21/20153,660,219
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR SIERRA ONCOLOGY INC
LOADING...